Flatunil 67 mg/mlFlatulence, abdominal distention, fullness, gas and windy colic: Flatunil 67 mg/ml is an excellent and effective antiflatulent. It is used for relief of the painful symptoms of excess gas in the digestive tract. Such gas is frequently caused by excessive swallowing of air or by eating foods ... Read moreFlatulence, abdominal distention, fullness, gas and windy colic: Flatunil 67 mg/ml is an excellent and effective antiflatulent. It is used for relief of the painful symptoms of excess gas in the digestive tract. Such gas is frequently caused by excessive swallowing of air or by eating foods that disagree. Flatunil 67 mg/ml drop is especially used in infants, acts in the stomach and intestines. Thus Flatunil 67 mg/ml enables freeing and eliminating the gas more easily by belching or passing flatus. Large bowel preparation: Addition of Flatunil 67 mg/ml to a polyethylene glycol bowel preparation produces symptomatic improvement prior to investigation in the management of accidental ingestion of foaming detergents. Treatment of poisoning: Flatunil 67 mg/ml has an anecdotal use as an antifoaming agent in the management of accidental ingestion of foaming detergents.Theropeutic ClassAnti-dyspeptic/CarminativesPharmacologyFlatunil 67 mg/ml is used as an antiflatulent to relieve symptoms commonly referred to gas including upper GI bloating, pressure, fullness or stuffed feeling. The clinical use of Simeticone is based on its antifoaming properties. Its antifoaming action relieves flatulence by dispersing and preventing the formation of mucous surrounded?gas pockets in the GI tract. Simeticone acts in the stomach and intestines to change the surface tension of gas bubbles, enabling them to coalesce; thus gas is freed and eliminated more easily by belching or passing flatus. Simeticone aids in the elimination of gas from the GI tract and can be used to reduce postoperative gas pains. Simeticone can also be used prior to gastroscopy to enhance visualization and prior to radiography of the intestine to reduce gas shadows.Dosage & Administration of Flatunil 67 mg/mlTake after meals and at bedtime. Can be given with infant?s feeds. Shake the bottle well before each use.
Children less than 2 years of age: 20 mg (0.3 ml Flatunil 67 mg/ml Paediatric Drops) 4 times daily up to 240 mg/day (3.6 ml Flatunil 67 mg/ml Paediatric Drops).
Children 2-12 years of age: 40 mg (0.6 ml Flatunil 67 mg/ml Paediatric Drops) 4 times daily.
Adults: 40-125 mg or 1-3 Flatunil 67 mg/ml chewable tablets; 4 times daily, up to 500 mg/day (12 Flatunil 67 mg/ml chewable tablets).
Dosage of Flatunil 67 mg/mlTake after meals and at bedtime. Can be given with infant's feeds. Shake the bottle well before each use.Children less than 2 years of age: 20 mg (0.3 ml Flatunil 67 mg/ml Paediatric Drops) 4 times daily up to 240 mg/day (3.6 ml Flatunil 67 mg/ml Paediatric Drops).Children 2-12 years of age: 40 mg (0.6 ml Flatunil 67 mg/ml Paediatric Drops) 4 times daily.Adults:
40-125 mg (0.6 ml-1.9 ml Flatunil 67 mg/ml Paediatric Drops) 4 times daily, up to 500 mg/day (7.5 ml Flatunil 67 mg/ml Paediatric Drops) or
1-3 Flatunil 67 mg/ml chewable tablets; 4 times daily, up to 500 mg/day (12 Flatunil 67 mg/ml chewable tablets).
Interaction of Flatunil 67 mg/mlThere is no evidence that Flatunil 67 mg/ml modifies the effect of other drugs. The defoaming effect of Flatunil 67 mg/ml is reduced by antacids such as Aluminium Hydroxide and Magnesium Carbonate, which absorb the Silicone.Side Effects of Flatunil 67 mg/mlFlatunil 67 mg/ml is physiologically inert and no adverse effect has been noted after oral ingestion.Pregnancy & LactationPregnant women: No data are available to suggest any harmful effects.Lactating mother: Excretion of Flatunil 67 mg/ml in breast milk has not been established, and would be most unlikely.Precautions & WarningsDo not exceed 12 doses per day except under the advice and supervision of a physician.Storage ConditionsShould be stored in cool and dry place, protected from light.?Keep the medicine out of the reach of children.Drug ClassesAnti-dyspeptic/CarminativesMode Of ActionFlatunil 67 mg/ml is used as an antiflatulent to relieve symptoms commonly referred to gas including upper GI bloating, pressure, fullness or stuffed feeling. The clinical use of Simeticone is based on its antifoaming properties. Its antifoaming action relieves flatulence by dispersing and preventing the formation of mucous surrounded?gas pockets in the GI tract. Simeticone acts in the stomach and intestines to change the surface tension of gas bubbles, enabling them to coalesce; thus gas is freed and eliminated more easily by belching or passing flatus. Simeticone aids in the elimination of gas from the GI tract and can be used to reduce postoperative gas pains. Simeticone can also be used prior to gastroscopy to enhance visualization and prior to radiography of the intestine to reduce gas shadows.PregnancyPregnant women: No data are available to suggest any harmful effects.Lactating mother: Excretion of Flatunil 67 mg/ml in breast milk has not been established, and would be most unlikely.
Wintrobe Stand, 6 Tubes ₦1,000.00
FORMONIDE FORTE RESPICAPS 30`S ₦9,033.75
Collins Big Cat All in a Month ₦1,600.00
Flatunil 67 mg/mlFlatulence, abdominal distention, fullness, gas and windy colic: Flatunil 67 mg/ml is an excellent and effective antiflatulent. It is used for relief of the painful symptoms of excess gas in the digestive tract. Such gas is frequently caused by excessive swallowing of air or by eating foods ... Read moreFlatulence, abdominal distention, fullness, gas and windy colic: Flatunil 67 mg/ml is an excellent and effective antiflatulent. It is used for relief of the painful symptoms of excess gas in the digestive tract. Such gas is frequently caused by excessive swallowing of air or by eating foods that disagree. Flatunil 67 mg/ml drop is especially used in infants, acts in the stomach and intestines. Thus Flatunil 67 mg/ml enables freeing and eliminating the gas more easily by belching or passing flatus. Large bowel preparation: Addition of Flatunil 67 mg/ml to a polyethylene glycol bowel preparation produces symptomatic improvement prior to investigation in the management of accidental ingestion of foaming detergents. Treatment of poisoning: Flatunil 67 mg/ml has an anecdotal use as an antifoaming agent in the management of accidental ingestion of foaming detergents.Theropeutic ClassAnti-dyspeptic/CarminativesPharmacologyFlatunil 67 mg/ml is used as an antiflatulent to relieve symptoms commonly referred to gas including upper GI bloating, pressure, fullness or stuffed feeling. The clinical use of Simeticone is based on its antifoaming properties. Its antifoaming action relieves flatulence by dispersing and preventing the formation of mucous surrounded?gas pockets in the GI tract. Simeticone acts in the stomach and intestines to change the surface tension of gas bubbles, enabling them to coalesce; thus gas is freed and eliminated more easily by belching or passing flatus. Simeticone aids in the elimination of gas from the GI tract and can be used to reduce postoperative gas pains. Simeticone can also be used prior to gastroscopy to enhance visualization and prior to radiography of the intestine to reduce gas shadows.Dosage & Administration of Flatunil 67 mg/mlTake after meals and at bedtime. Can be given with infant?s feeds. Shake the bottle well before each use. Children less than 2 years of age: 20 mg (0.3 ml Flatunil 67 mg/ml Paediatric Drops) 4 times daily up to 240 mg/day (3.6 ml Flatunil 67 mg/ml Paediatric Drops). Children 2-12 years of age: 40 mg (0.6 ml Flatunil 67 mg/ml Paediatric Drops) 4 times daily. Adults: 40-125 mg or 1-3 Flatunil 67 mg/ml chewable tablets; 4 times daily, up to 500 mg/day (12 Flatunil 67 mg/ml chewable tablets). Dosage of Flatunil 67 mg/mlTake after meals and at bedtime. Can be given with infant's feeds. Shake the bottle well before each use.Children less than 2 years of age: 20 mg (0.3 ml Flatunil 67 mg/ml Paediatric Drops) 4 times daily up to 240 mg/day (3.6 ml Flatunil 67 mg/ml Paediatric Drops).Children 2-12 years of age: 40 mg (0.6 ml Flatunil 67 mg/ml Paediatric Drops) 4 times daily.Adults: 40-125 mg (0.6 ml-1.9 ml Flatunil 67 mg/ml Paediatric Drops) 4 times daily, up to 500 mg/day (7.5 ml Flatunil 67 mg/ml Paediatric Drops) or 1-3 Flatunil 67 mg/ml chewable tablets; 4 times daily, up to 500 mg/day (12 Flatunil 67 mg/ml chewable tablets). Interaction of Flatunil 67 mg/mlThere is no evidence that Flatunil 67 mg/ml modifies the effect of other drugs. The defoaming effect of Flatunil 67 mg/ml is reduced by antacids such as Aluminium Hydroxide and Magnesium Carbonate, which absorb the Silicone.Side Effects of Flatunil 67 mg/mlFlatunil 67 mg/ml is physiologically inert and no adverse effect has been noted after oral ingestion.Pregnancy & LactationPregnant women: No data are available to suggest any harmful effects.Lactating mother: Excretion of Flatunil 67 mg/ml in breast milk has not been established, and would be most unlikely.Precautions & WarningsDo not exceed 12 doses per day except under the advice and supervision of a physician.Storage ConditionsShould be stored in cool and dry place, protected from light.?Keep the medicine out of the reach of children.Drug ClassesAnti-dyspeptic/CarminativesMode Of ActionFlatunil 67 mg/ml is used as an antiflatulent to relieve symptoms commonly referred to gas including upper GI bloating, pressure, fullness or stuffed feeling. The clinical use of Simeticone is based on its antifoaming properties. Its antifoaming action relieves flatulence by dispersing and preventing the formation of mucous surrounded?gas pockets in the GI tract. Simeticone acts in the stomach and intestines to change the surface tension of gas bubbles, enabling them to coalesce; thus gas is freed and eliminated more easily by belching or passing flatus. Simeticone aids in the elimination of gas from the GI tract and can be used to reduce postoperative gas pains. Simeticone can also be used prior to gastroscopy to enhance visualization and prior to radiography of the intestine to reduce gas shadows.PregnancyPregnant women: No data are available to suggest any harmful effects.Lactating mother: Excretion of Flatunil 67 mg/ml in breast milk has not been established, and would be most unlikely.
